Pollock A S, Arieff A I
Am J Physiol. 1980 Sep;239(3):F195-205. doi: 10.1152/ajprenal.1980.239.3.F195.
Disturbances of body fluid osmolality are common as clinical entities. The primary clinical manifestations of both hyper- and hyposmolal states are central nervous system dysfunction. With hyperosmolal perturbations in plasma osmolality, the brain, like other tissues, initially acts as a "perfect osmometer," passively shrinking as a result of secondary substantial cellular water loss. In hours to days, depending on the extracellular solute, restoration of brain volume may be achieved if the solute is endogenous (Na+, urea, glucose). This occurs largely by the generation of new, nonelectrolyte intracellular solute in brain. This de novo solute appears only when hyperosmolality is caused by endogenous substances and not with mannitol, glycerol, or radiographic contrast media. Under the latter circumstances, the brain remains dehydrated and idiogenic osmoles are not observed. In hyposmolal states, the brain initially acts as an "imperfect osmometer," expanding its volume less than expected on the basis of passive water movement. Other tissues (red cell, muscle, and liver) behave more as perfect osmometers. In time, restoration of cell volume is achieved largely through loss of intracellular electrolytes (Na+ and K+) and other solutes such as amino acids. Teleologically, these mechanisms appear to protect brain volume at the expense of the intracellular milieu. The resultant alteration of intracellular composition may be largely responsible for the diffuse alterations in brain function observable in patients and experimental animals with such afflictions.
体液渗透压紊乱作为临床病症很常见。高渗和低渗状态的主要临床表现都是中枢神经系统功能障碍。随着血浆渗透压出现高渗性扰动,大脑与其他组织一样,最初就像一个“完美的渗透计”,由于继发的大量细胞失水而被动萎缩。在数小时至数天内,取决于细胞外溶质,如果溶质是内源性的(钠、尿素、葡萄糖),脑容量可能恢复。这主要是通过在脑内生成新的非电解质细胞内溶质来实现的。这种新生成的溶质仅在高渗由内源性物质引起时出现,而在使用甘露醇、甘油或造影剂时则不会出现。在后一种情况下,大脑仍处于脱水状态,且未观察到内生性渗透分子。在低渗状态下,大脑最初就像一个“不完美的渗透计”,其体积增加量小于基于被动水移动所预期的量。其他组织(红细胞、肌肉和肝脏)的表现更像完美的渗透计。随着时间推移,细胞体积的恢复主要是通过细胞内电解质(钠和钾)以及其他溶质(如氨基酸)的丢失来实现的。从目的论角度来看,这些机制似乎是以细胞内环境为代价来保护脑容量。由此导致的细胞内成分改变可能在很大程度上是患有此类病症的患者和实验动物中可观察到的脑功能弥漫性改变的原因。